| Thursday 13th October 2005 |
C1 - PHOTODERMATOLOGY
Chair: J. Hawk (UK)
Co-chairs: G. Leone (Italy), R. Roelandts (Belgium) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- Describe the interactions of ultraviolet radiation with skin.
- Outline the pathogenesis of normal and abnormal skin reactions to sunlight.
- Prevent or treat these reactions effectively.
DESCRIPTION
The nature of ultraviolet damage to skin, the nature of the common photodermatoses, particular polymorphic light eruption, the efficiency of sunscreens and more specific treatments, and the value of preventive phototherapy will be discussed. The session is for both general dermatologists and those with a particular interest in photodermatology. |
| Morning session |
| 08.30 |
C1.1 |
Ultraviolet Radiation (UVR): Its Production, Nature and Interactions with Matter - H-C. Wulf (Denmark). |
| 08.50 |
C1.2 |
UVR Induced Molecular Effects in Skin – J. Krutmann (Germany) |
| 09.10 |
C1.3 |
UVR- Induced Immunology Changes in Skin – T. Schwarz (Germany) |
| 09.30 |
C1.4 |
Acute Effects of Skin UVR Exposure: Eryhema, Pigmentation and Hyperplasia – H. Hönigsmann (Austria) |
| 09.50 |
C1.5 |
Chromic Effects of Skin UVR Exposure: Photoageing and Photocarcinogenisis – A. Young (UK) |
| |
|
Coffee Break |
| 10.30 |
C1.6 |
Photoprotection and the Efficacy of Sunscreens – G. Murphy (Ireland) |
| 10.45 |
C1.7 |
Investigative Techniques in Clinical Photobiology – J. Ferguson (UK) |
| 11.00 |
C1.8 |
Discussion |
| 11.10 |
C1.9 |
Polymorphic Light Eruption, Actinic Prurigo and Hydroa Vacciniforme – R. Roelandts (Belgium) |
| 11.30 |
C1.10 |
Chronic Actinic Dermatitis – J. Hawk (UK) |
| Afternoon session |
| 14.30 |
C1.11 |
Solar Urticaria – R. Palmer (UK) |
| 14.45 |
C1.12 |
The Light-Exacerbated Dermatoses – P. Thomas (France) |
| 15.00 |
C1.13 |
Chemical and Drug Induced Photosensitivity – S. Ibbotson (UK) |
| 15.15 |
C1.14 |
The Cutaneous Porphyrias – M. Lecha (Spain) |
| 15.30 |
C1.15 |
Phototherapy – H. Lim (USA) |
| 15.50 |
C1.16 |
Discussion and Close |
| |
| Thursday 13th October 2005 |
C2 - CONTACT & OCCUPATIONAL DERMATITIS
Chair: T. Menné (Denmark)
Co-chairs: D. Bruynzeel (Netherlands) R. Rycroft (UK) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- Irritant and allergic contact dermatitis, epidemiology and basic mechanisms.
DESCRIPTION:
The session includes all aspects of irritant and allergic contact dermatitis including basic mechanisms, epidemiology, investigative methods and clinical aspects. The session will deal with allergic contact dermatitis to specific ingredients including cosmetic allergy and occupational dermatoses. |
| Morning session |
| 08.30 |
C2.1 |
Gene expression profiling in allergic contact dermatitis – I. Kimbler (UK) |
| 08.55 |
C2.2 |
Epidemiology of hand eczema – B. Meding (Sweden) |
| 09.20 |
C2.3 |
Contact dermatitis in the car industry – T. Diepgen (Germany) |
| 09.45 |
C2.4 |
Occupational contact dermatitis in Great Britain – M. Beck (UK) |
| 10.15 |
C2.5 |
New important contact allergens in cosmetics – A. Goossens (Netherlands) |
| 10.45 |
C2.6 |
Exposure to irritants and wet work in the health care sector – F. Jungbauer (Netherlands) |
| 1.15 |
C2.7 |
Contact dermatitis in health personal – A.M. Giménez Arnau (Spain) |
| Afternoon session |
| 14.30 |
C2.8 |
Evidence based dermatitis in the windmill industry – T. Agner (Denmark) |
| 14.50 |
C2.9 |
Occupational epoxy dermatistis in the windmill industry – M. Bruze (Sweden) |
| 15.15 |
C2.10 |
The factory visit – R. Rycroft (UK) |
| 15.40 |
C2.11 |
Treatment of hand eczema - N. Veien (Denmark) |
| 16.00 |
C2.12 |
Close |
| |
| Thursday 13th October 2005 |
C3 - COSMETIC AND LASER DERMATOLOGY
Chair: A. Troilius (Sweden)
Co-chairs: A. Camps- Fresneda (Spain) L. Polla (Switzerland) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- Learn what is possible today within the laser and IPI treatment field of Vascular, Pigment and Photorejuvination area.
- Be aware of the drawbacks and side effects!
- Know the latest news about laser and IPL and the future posibilities within these fields.
DESCRIPTION
This course will cover most of the lasers and IPL treatments within the cosmetic field. The course will be instructional but also updates and news. Where are we now and where are are we going within this field? Is this what our patients want from us? |
Morning session
LASER AND IPL TREATMENT OF VASCULAR |
| 08.30 |
C3.1 |
Telangiectatic lesions and Rosacea, when laser or IPL will be useful – A. Camps Fresneda (Spain) |
| 08.45 |
C3.2 |
Success and limits of laser in leg ecstatic vessels – L. Polla (Italy) |
| 09.00 |
C3.3 |
Vascular malformations - Port wine stains –can we avoid the hyperthropic development? - S. Laningan (UK) |
| 09.15 |
C3.4 |
Hemangiomas –incl. ulcerated difficult cases – M. Landthaler (Germany) |
| PIGMENT |
| 09.45 |
C3.6 |
Melasma, Café au lait –Hyper and hypo-pigmentation - Pathophysiology, medical treatment, peeling treatment – C. Rowland Payne (UK) |
| 10.00 |
C3.7 |
Melasma , Café au lait –Hyper and hypo-pigmentation – treatment with lasers or IPL – L. Polla (Italy) |
| TATTOOS |
| 10.15 |
C3.8 |
Decorative tattoo - what's new? Laws & regulations – M. Adatto (Switzerland) |
| 10.30 |
C3.9 |
Traumatic tattoos –different result depending on foreign material? – A. Troilius (Sweden) |
| 10.45 |
C3.10 |
Hair removal- regrowth? Can we treat blond, red and grey hair? Hormonal diseases – M. Drosner (Germany) |
| 11.00 |
C3.11 |
Becker’s Nevi & Hairy Nevi – M. Trelles (Spain) |
| PHOTO REJUVINATION: |
| 11.15 |
C3.12 |
Lasers as a part of systemic rejuvenation program- O. Bogomolets (Ukraine) |
| 11.30 |
C3.13 |
Updates in resurfacing and non-ablative field – R. Fitzpatrick (USA) |
| NON ABLATIVE PHOTO REJUVENATION |
| 11.45 |
C3.14 |
Non-thermal mechanisms assisting thermal photorejuvenation: LEDs and beyond” – R. A. Weiss (USA) |
Afternoon session
ACNE - SCARS |
| 14.30 |
C3.15 |
Acne scar revision - L. Rusciani (Italy) |
| 14.45 |
C3.16 |
Acne treatment with IPL and laser– A. Troilius (Sweden) |
| 15.00 |
C3.17 |
Laser for treatment of Scars – N. Keyvan (USA) |
| 15.15 |
C3.18 |
Is vitiligo & hypopigmented scars possible to treat with lasers? – K. Fritz (Germany) |
| 15.30 |
C3.19 |
Psoriasis – P. Bjerring (Denmark) |
| 15.45 |
C3.20 |
"On Avoiding Laser Litigation" – J. Cotterill (UK) |
| 16.00 |
C3.21 |
”What’s next?” – C. Dierickx (Belgium) |
| 16.15 |
|
Course evaluation |
| 16.30 |
|
Close |
| |
| Thursday 13th October 2005 |
C4 - INFECTIOUS DISEASES OF THE SKIN
Chair: C. Cocuzza (Italy)
Co-chairs: O. Chosidow (France) S. Buechner (Switzerland) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- Know the causative agents, pathogenesis and epidemiology of some of the more important infectious diseases of the skin.
- Recognise the clinical presentation and know how to make a diagnosis of the infectious diseases discussed.
- Learn the current opinions on the prevention and management of these diseases.
DESCRIPTION
This course is aimed at providing updated knowledge on those which have been considered the most important infectious diseases of the skin. Relevant bacterial, viral, fungal and parasitic infections of the skin will be discussed together with the pathogenesis and the various clinical presentation associated with them. Importance will be given also to some travel imported infectious diseases of the skin. The epidemiology emerging or “remerging” pathogens worldwide will be described. The diagnostic tools available to dermatologists for the diagnosis of infectious diseases of the skin, together with some recent advances in the laboratory methods will be discussed. Updated prevention and management schemes will be discussed as well as describing some of the possible therapeutic problems encountered in the treatment of these diseases, such as drug resistance. |
| Morning session |
| 08.30 |
C4.1 |
Advances in the Laboratory Diagnosis of Infectious Diseases - C. Cocuzza (Italy) |
| 08.55 |
C4.2 |
Superficial and deep bacterial infections of the skin - Ph Bernard (France) |
| 09.20 |
C4.3 |
Tropical diseases, including leprosy, and the dermatologist - D. Lockwood (UK) |
| 09.45 |
C4.4 |
Typical and atypical cutaneous manifestations of Borreliosis - S. Buechner (Switzerland) |
| 10.10 |
C4.5 |
Syphilis and Gonorrhoea in Europe: epidemiological and thepeutics overview - E. Tschachler, Vienna |
| 10.35 |
C4.6 |
Evidence and non evidence for the treatment of genital and non genital warts - G. Gross (Germany) |
| 11.00 |
C4.7 |
Genital herpes - W. Kempf (Switzerland) |
| 11.25 |
C4.8 |
Epidemiology and management of tinea capitis in european children - R. Hay (UK) |
| Afternoon session |
| 14.30 |
C4.9 |
Cutaneous Leishmaniasis - M. Mohkni (Tunisia) |
| 14.55 |
C4.10 |
Scabies and pediculosis - O. Chosidow (France) |
| 15.20 |
C4.11 |
Emerging and re-emerging infectious exanthemas - C. Gelmetti (Italy) |
| 15.45 |
C4.12 |
Atypical Mycobacterial infections – K.J. Tomecki (USA) |
| |
| Thursday 13th October 2005 |
| C5 - PAEDIATRIC DERMATOLOGY
Chair: C. Moss (UK)
Co-chairs: P. Hoeger (Germany) A. Taieb (France) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- Appreciate the importance of paediatric issues in managing children with skin disease.
- Feel confident in approaching a neonate with skin problems.
- Understand the importance of psychological issues in paediatric dermatology.
DESCRIPTION:
Recent high profile cases have highlighted the importance of children being cared for by professionals with understanding of paediatric issues. Paediatric Dermatology is usually taught by dermatologists, but we must be prepared to learn from paediatricians and psychologists. The emphasis of this session is on paediatric and psychological issues relevant to the practice of paediatric dermatology. This course, which is taught by paediatricians as well as dermatologists, is suitable for all doctors whose practice includes children with skin disorders. |
Morning session
GENERAL PAEDIATRIC DERMATOLOGY |
| 08.30 |
C5.1 |
Dermatologists' guide to paediatric resuscitation – H. Goodyear (UK) |
| 08.55 |
C5.2 |
Modern management of paediatric burns – V. Casoli (France) |
| 09.15 |
C5.3 |
Uncommon viral exanthems in childhood – C. Labreze (France) |
| 09.35 |
C5.4 |
Dermatologists' guide to paediatric prescribing – A. Martinez (UK) |
| |
|
Coffee break |
| NEONATAL DERMATOLOGY |
| 10.15 |
C5.5 |
Dermatologists' guide to the Neonatal Unit – H. Ott (Germany) |
| 10.40 |
C5.6 |
Physiology of neonatal skin: Postnatal adaptation/maturation of skin function and its clinical implications – P. Hoeger (Germany) |
| 11.00 |
C5.7 |
Differential diagnosis of pustulation in the neonate – A. Taieb (France) |
| 11.20 |
C5.8 |
Management of the collodion baby – D. Hohl (Switzerland) |
Afternoon session
PSYCHOSOCIAL ASPECTS OF PAEDIATRIC DERMATOLOGY |
| 14.30 |
C5.9 |
The psychological needs of children with skin disease - H. Dennis (UK) |
| 14.55 |
C5.10 |
Dermatitis artefacta – C. Moss (UK) |
| 15.15 |
C5.11 |
Skin disease and body image – T. Bewley (UK) |
| 15.35 |
C5.12 |
Measuring quality of life in children with skin disorders – S. Lewis-Jones (UK) |
| |
| Friday 14th October 2005 |
| C6 - DERMATOIMMUNOLOGY AND ALLERGIC SKIN DISEASE
Chair: C. Grattan (UK)
Co-chairs: C. Bindslev-Jensen (Denmark) J. Simon (Germany) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- Understand the diversity and functions of the immune system
- Apply this knowledge to the understanding of allergy and autoimmunity in the skin
- Be up-to-date with current views on the role of the immune system in skin disease
DESCRIPTION
The course is aimed at clinicians with an interest in immunological and allergic skin disorders including psoriasis, atopic dermatitis, allergic contact dermatitis, drug reactions, urticaria and anaphylaxis, hereditary angio-oedema, connective tissue diseases and immunobullous diseases. The introductory talks will provide an overview of the innate and adaptive immune systems and the principles of allergy and autoimmunity. The subsequent talks will focus on the pathogenesis and clinical presentation of specific skin problems, each given by experts in their field. There will be a discussion after each session. |
| Morning session |
| 08.30 |
C6.1 |
The innate immune system – C. Grattan (UK) |
| 08.50 |
C6.2 |
The adaptive immune system – S. Beissert (Germany) |
| 09.10 |
C6.3 |
Principles of allergy – C. Bindslev-Jensen (Denmark) |
| 09.30 |
C6.4 |
Principles of autoimmunity – U. Haustein (Germany) |
| 09.50 |
|
Discussion |
| |
|
Coffee break |
| 10.15 |
C6.5 |
Psoriasis – P. van de Kerkhof (Netherlands) |
| 10.35 |
C6.6 |
Immuno-bullous diseases – V. Venning (UK) |
| 10.55 |
C6.7 |
Allergic contact dermatitis – J. Simon (Germany) |
| 11.15 |
C6.8 |
Drug Reactions – P. Friedman (UK) |
| 11.35 |
|
Discussion |
| Afternoon session |
| 14.30 |
C6.9 |
Urticaria and anaphylaxis – T. Zuberbier (Germany) |
| 14.50 |
C6.10 |
Hereditary angio-oedema – M. Cicardi (Italy) |
| 15.10 |
C6.11 |
Atopic eczema – G. Ogg (UK) |
| 15.30 |
C6.12 |
Connective tissue diseases – M. Goodfield (UK) |
| 15.50 |
|
Interactive Discussion |
| 16.00 |
|
Close |
| |
| Friday 14th October 2005 |
| C7 - SEXUALLY TRANSMITTED DISEASES
Chair: R. Patel (UK)
Co-chairs: A. Proder (Estonia) A. Stary (Austria) |
LEARNING OBJECTIVES:
- Understand the changing and evolving epidemiology of STIs.
- Understand the use of newer serological/molecular methods for diagnosing STIs.
- Appreciate the common pitfalls of STI management.
DESCRIPTION:
Despite their frequency common STIs are frequently mismanaged – we will review our understanding, diagnosis and management of these. There has been a re-emergence of some classical STIs within Europe- New technologies are being exploited to assist rapid and accurate diagnosis. This session will interest any Dermatoveneriologists who provide STI care in there practice. |
| Morning session |
| 08.30 |
|
Introduction – R. Patel (UK) |
| 08.40 |
C7.1 |
What is NSU – The role of genital Mycoplasmas in Urethritis – P. Horner (UK) |
| 09.10 |
C7.2 |
The role of genital Mycoplasmas in PID – J. Ross (UK) |
| 09.40 |
C7.3 |
Dispelling myths about vaginal discharge – J. Wilson (UK) |
| |
|
Coffee Break |
| 10.30 |
C7.4 |
Understanding syphilis serology – S. Macmillan (UK) |
| 10.50 |
C7.5 |
Fine print in syphilis – what does the clinician need to know? – B. Goh (UK) |
| 11.10 |
C7.6 |
Dispelling myths about genital herpes – A. Proder (Estonia) & R. Patel (UK) |
| Afternoon session |
| 14.30 |
C7.7 |
LGV – I. Martin (UK) |
| 15.00 |
C7.8 |
Which antibiotic for GC today? - C. Ison (UK) |
| 15.20 |
C7.9 |
Models of STI care across Europe
– V. Griffiths (UK) |
| 15.40 |
C7.10 |
The future for STI guidelines in Europe – K. Radcliffe (UK) |
| 16.00 |
|
Close |
| |
| Friday 14th October 2005 |
| C8 - DERMATOPATHOLOGY
Chair: E. Calonje (UK)
Co-chairs: L. Cerroni (Austria) D. Metze (Germany) |
LEARNING OBJECTIVES: at the end of the course participants should be able to:
- Develop a systematic approach to the histological diagnosis of difficult benign melanocytic lesions arising at special body sites or in children and problematic malignant melanocytic lesions arising in children or presenting with unusual histological features.
- Correlate clinical presentation with histopathological features in benign and malignant melanocytie lesions and in a wide range on inflammatory dermatoses.
- Be able to generate a coherent list of histological differential diagnosis in the different patterns of inflammatory dermatoses and recognise new observations in the filed of inflammatory dermatoses.
DESCRIPTION:
The dermatopathology course will cover 2 main subjects including neoplastic dermatopathology (melanocytic lesions) and inflammatory dermatoses (an overview). The course is not all-inclusive but covers areas of dermatopathology that are of great interest to dermatologists and dermatopathologists alike. The subjects in the part of the course devoted to melanocytic tumours have been selected taking into account the relevance of correlation between clinical presentation and histopathological appearances. It emphasizes areas of melanocytic pathology where histological diagnosis is often difficult. It includes four thirty-minute lectures consisting of melanocytic naevi at special body sites and unusual melanomas.
The part devoted to inflammatory dermatoses will provide an overview of all patterns of inflammatory dermatoses with emphasis on clinicopathological correlation and recent observations. After covering the classical patterns of inflammatory dermatoses in certain depth, there will be a final lecture on unusual histological presentations of common inflammatory skin disorders to illustrate the histological overlap that is sometimes seen in skin diseases. |
| Morning session |
| 09.30 |
C8.1 |
Clinicopathological correlations of melanocytic tumours – L. Cerroni (Austria) |
| 09.00 |
C8.2 |
Melanocytic naevi at special body sites – H. Kutzner (Germany) |
| 09.30 |
C8.3 |
Melanocytic tumours in childhood – M. Canninga (Netherlands) |
| 10.00 |
C8.4 |
Unusual melanomas – E. Calonje (UK) |
| |
|
Coffee Break |
| 10.45 |
C8.5 |
Spongiotic dermatitis – G. Borroni (Italy) |
| 11.15 |
C8.6 |
Psoriasiform dermatitis – K. Kerl (Switzerland) |
| Afternoon session |
| 14.30 |
C8.7 |
Lichenoid dermatitis –
D. Metze (Germany) |
| 14.50 |
C8.8 |
Granulomatous dermatitis – R. Cerio (UK) |
| 15.10 |
C8.9 |
Panniculitis – L. Requena
(Spain) |
| 15.30 |
C8.10 |
Invisible dermatoses – C. Tomasini (Italy) |
| 15.45 |
C8.11 |
Exception to the rule: Unusual histological presentations of inflammatory skin disorders – B. Cribier (France) |
| 16.00 |
|
Close |
| |
| Saturday 15th October 2005 |
| C9 - DERMATOLOGICAL SURGERY TECHNIQUES
Chair: E. Haneke (Germany)
Co-chairs: A. Picoto (Portugal) R. Motley (UK) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- To give an overview of both important old and new techniques and developments so that both the beginner and the experienced in dermatological surgery can profit from attending the course.
DESCRIPTION
This will be a formal lectures session with – hopefully – enough time to discuss questions from the audience, both right after the lectures as well as in the final discussion.
The course will start with an introduction of anatomical particularities of different skin regions. Useful suture techniques will be described. The advantages and disadvantages of electro- and radiosurgery, also compared with the CO2 laser will follow and then lasers as surgical tools for the dermatological surgeon will be presented. A brief overview of the use of grafts in skin surgery will be presented. How a flap is designed, how it can be used and which different flaps are best for specific regions will be demonstrated. Mohs surgery as the treatment of choice for tumours in difficult locations and with ill-defined borders as well as new indications will be discussed. Treatment option for spider veins, not a serious but often embarrassing condition, will be presented and critically discussed. Nail surgery as an emerging subspeciality of dermatological surgery will be demonstrated. The subject of ablating a dark-skinned person will also be discussed. Finally, the medical use of fillers will be shown. |
| 08.30 |
|
Welcome – E. Haneke (Germany) |
| 08.40 |
C9.1 |
Anatomy with particular reference to difficult locations – P. Holt (UK) |
| 08.55 |
C9.2 |
Sutures – E. Haneke (Germany) |
| 09.10 |
C9.3 |
Electro- and radiosurgery – R. Motley (UK) |
| 09.25 |
C9.4 |
Lasers as surgical tools – L. Marini (Italy) |
| 09.40 |
C9.5 |
Grafts – C. Altinyazar (Turkey) |
| 09.55 |
C9.6 |
How to design a flap – F. Camacho (Spain) |
| 10.10 |
C9.7 |
Reconstruction of defects of the nose after Mohs’ surgery with full thicknes skin grafts – A. Picoto (Portugal) |
| 10.25 |
C9.8 |
Spider veins – what to do? – M. Neumann (Netherlands) |
| 10.40 |
C9.9 |
Nail surgery – N. DiChiacchio (Brazil) |
| 11.05 |
C9.10 |
Skin ablation in dark-complexioned subjects – M. Sachdev (India) |
| 11.20 |
C9.11 |
Medical indications for fillers – P. Andre (France) |
| 11.35 |
|
Final discussion |
| 11.45 |
|
Close |
| |
| Saturday 15th October 2005 |
| C10 - HUMAN IMMUNODEFICIENCY VIRUS
Chair: M. Nelson (UK)
Co-chairs: M. Conant (USA) J. Delescluse (Belgium) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- To become aware of recent changes of drug therapy and strategies for treatment of HIV
- To comprehend the metabolic toxicities of agents to treat HIV disease
- To understand the interactions between HIV and sexually transmitted diseases
- To be able to prevent diagnose and treat primary HIV infection
- To understand and be able to diagnose and treat infections and neoplasm of the skin which are common in those living with HIV disease
DESCRIPTION
This symposium will discuss the interactions between HIV disease, the skin, and sexually transmitted infections. An update will be given on antiviral therapy so that attendants are aware of the most modern strategies and therapeutic options in the treatment of HIV disease. A discussion of the lipodystrophic syndrome, and the manifestations and treatment of this distressing condition which complicates treatment of HIV infected individuals will follow. We will then move on to a discussion of primary HIV infection and its prevention and treatment, followed by a discussion of sexually transmitted infections, including hepatitis C, and HIV. Finally we will discuss dermatological manifestions of HIV including fungal infections of the skin, human papilloma virus and HIV related tumours. |
08.30 |
C10.1 |
Antiviral therapy - where are we now – B. Gazzard (UK) |
| 08.55 |
C10.2 |
The lipodystrophy syndrome - manifestations and treatment – G. Moyle (UK) |
| 09.20 |
C10.3 |
Primary HIV infection - prevention and treatment – M. Fisher (UK) |
| 09.45 |
C10.4 |
Sexually transmitted infections and HIV – S. Portsmouth (UK) |
| 10.15 |
C10.5 |
Fungal infections of the skin and HIV - J. Delecleuse (Belgium) |
| 10.45 |
C10.6 |
HIV and HPV – M. Conant (USA) |
| 11.15 |
C10.7 |
HIV related tumours – M. Bower (UK) |
| 11.45 |
|
Close |
| |
| Saturday 15th October 2005 |
| C11 - COURSE GENETICS IN DERMATOLOGY
Chair: D. Hohl (Switzerland)
Co-chairs: J. Frank (Germany) D. Kelsell (UK) |
LEARNING OBJECTIVES - Following this session, the attendee will be able to:
- Knowledge on techniques and methods
- Knowledge on disease mechanisms
- Knowledge on genetic diseases
DESCRIPTION
At the end of this course, each participant should understand the techniques to identify genes responsible for monogenic and complex genetic diseases, know the most common genodermatoses and have an insight into the respective pathogenic mechanisms. |
| 08.30 |
C11.1 |
Mapping of monogenic and complex diseases - J. Fischer (France) |
| 08.50 |
C11.2 |
SNP mapping of skin diseases – D. Kelsell (UK) |
| 09.10 |
C11.3 |
Ichthyoses – H. Traupe (Germany) |
| 09.30 |
C11.4 |
Ectodermal dysplasia – J. McGrath (UK) |
| 09.50 |
C11.5 |
Bullous diseases – G. Zambruno (Italy) |
| |
|
Coffee break |
| 10.25 |
C11.6 |
Collagen disorders - L. Bruckner-Tuderman (Germany) |
| 10.45 |
C11.7 |
Vascular and mosaic disorders – P. Itin (Switzerland) |
| 11.05 |
C11.8 |
Metabolic genodermatoses and porphyrias – J. Frank (Germany) |
| 11.25 |
C11.9 |
Hereditary tumor-syndromes – D. Hohl (Switzerland) |